Dermatology drugmaker Journey Medical has trekked its Dr. Reddy’s Laboratories-partnered rosacea med across the FDA finish line as Emrosi. | The drug proved superiority in clearing lesions over ...
Rosacea treatment Emrosi will mark the latest offering in Journey Medical’s portfolio of dermatological treatments. Others include Accutane, Ximino and Amzeeq (all for varying severities of acne) and ...
Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in adults, drugmaker Journey Medical ...